Clinical trials rely upon speed and accuracy to deliver new drugs and medicines to the public. Limiting the potential for unwanted variables that can skew the data is critical. One of these issues is professional research subjects or duplicate subjects in clinical trials. These particular participants often times have motives to partiicapte in the particular …
Clinical research patients are compensated for their participation in clinical trials. In some therapeutic areas and types of clinical trials, the compensation for enrolling in one or more clinical trials or at multiple research sites is enough to influence patients to join more than one contemporaneously and expose themselves to multiple investigational products or multiple …
Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …
Clinical trials around the world face challenges from professional research subjects or dual enrollment in clinical trials. One group of subjects that have high rates of participation in clinical research are subjects who enroll in multiple trials for the purpose of generating income through study payments or using clinical trials as medical care. These subjects …
Conducting virtual clinical trials or remote clinical trials, or just a standard clinical trial? Verify your research subject’s eligibility and ensure they are not concurrently enrolling in multiple clinical trials at once. Verified Clinical Trials eliminates professional research subjects or duplicate research subjects. This can be accomplished completely off site with our newest technology. Avoid …
Duplicate or professional research subjects can be the silent killer of your clinical trial. The issue exists in all phases of clinical trials research, across the globe and across most therapeutic areas. As the data grows, we realize how important it is to use the Verified Clinical Trials (VCT) research subject registry to prevent these …
We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials or professional research subjects over the past few years. Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …
Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and as well as other protocol violations. The workshop …
Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations. Up to 10% in CNS clinical trials and much higher …
Your clinical trial is not meeting it’s endpoints and upon review, you detect there are duplicate subjects in your study. You and your teams spend several months trying to weed out these duplicate subjects. A new study must be performed. We hear this all the time. It occurs across most therapeutic indications and across the …
